Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.02 +1.35%
Financial Fact:
Net Revenues Total: 180.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net Revenues Total: 180.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $1.13, $0.14 better than the analyst estimate of $0.99. Revenue for the quarter came in at $572.1 million versus the consensus estimate of $508.62 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Marex Group PLC (MRX) PT Raised to $90 at Keefe, Bruyette & Woods
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
